Abstract
The article presents modern concepts of “cardiovascular continuum”, where there are stages of heart disease risk factors up to death. The fundamental constant is a magnesium deficiency as a risk factor for endothelial dysfunction. The authors show the way of absorption, distribution of the elimination of magnesium, the regulatory significance of genes, providing its bioavailability. Symptoms of magnesium deficiency on the part of the cardiovascular system are characterized. The authors specify the involvement of magnesium in the develop-ment of metabiological syndrome, the possibilities of correction of its content, respectively, and insulin resis-tance. An anti-arrhythmogenic effect of the drug magnesium – Magnerot - was proven.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
